Published in J Inflamm (Lond) on May 28, 2005
NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis (2010) 1.84
A protective role for ELR+ chemokines during acute viral encephalomyelitis. PLoS Pathog (2009) 1.23
Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection. BMC Immunol (2013) 1.02
CXCR2: From Bench to Bedside. Front Immunol (2012) 1.01
Inhibitor of differentiation 1 promotes endothelial survival in a bleomycin model of lung injury in mice. Am J Pathol (2007) 0.98
Orally administered Lactobacillus rhamnosus modulates the respiratory immune response triggered by the viral pathogen-associated molecular pattern poly(I:C). BMC Immunol (2012) 0.97
A subset of epithelial cells with CCSP promoter activity participates in alveolar development. Am J Respir Cell Mol Biol (2010) 0.95
Gene expression changes in peripheral blood mononuclear cells during measles virus infection. Clin Vaccine Immunol (2007) 0.92
Toll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells. Am J Pathol (2010) 0.91
Role of neutrophils in response to Bordetella pertussis infection in mice. Infect Immun (2008) 0.90
Rat coronaviruses infect rat alveolar type I epithelial cells and induce expression of CXC chemokines. Virology (2007) 0.88
ELR(+) chemokine signaling in host defense and disease in a viral model of central nervous system disease. Front Cell Neurosci (2014) 0.86
The chemokine receptor CXCR2 and coronavirus-induced neurologic disease. Virology (2013) 0.77
Neutrophils and viral-induced neurologic disease. Clin Immunol (2016) 0.75
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature (2001) 25.15
The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med (2004) 17.08
When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology (1996) 4.02
Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest (2002) 3.08
Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis (1996) 2.72
CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect Immun (2000) 2.66
Chemokine binding and activities mediated by the mouse IL-8 receptor. J Immunol (1995) 2.59
CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J Immunol (1999) 2.56
The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J Immunol (1995) 2.37
Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med (2000) 2.29
Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol (2005) 2.21
Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest (1996) 2.20
Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol (2003) 2.20
Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun (2002) 2.19
Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest (1995) 2.05
Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods (1983) 1.98
Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol (2002) 1.95
Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J Immunol (1999) 1.90
IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol (1999) 1.87
Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun (1996) 1.84
Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol (1999) 1.77
Detection of microorganisms in the tracheal aspirates of preterm infants by polymerase chain reaction: association of adenovirus infection with bronchopulmonary dysplasia. Pediatr Res (2000) 1.72
The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J Biol Chem (1994) 1.72
CXCR2 is critical to hyperoxia-induced lung injury. J Immunol (2004) 1.65
Transvascular flux and tissue accrual of Evans blue: effects of endotoxin and histamine. J Lab Clin Med (1988) 1.55
Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection. J Immunol (2000) 1.48
Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation. J Immunol (2002) 1.41
Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J Immunol (1997) 1.39
IL-12 attenuates bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2001) 1.29
IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis. J Clin Invest (2002) 1.29
Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J Virol (2004) 1.28
Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med (2001) 1.24
Viral double-stranded RNA, cytokines, and the flu. J Interferon Cytokine Res (2000) 1.22
The role of the CC chemokine, RANTES, in acute lung allograft rejection. J Immunol (2000) 1.20
Mouse strain differences in the chemokine response to acute lung infection with a murine gammaherpesvirus. Viral Immunol (2004) 1.17
Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats. J Pharmacol Exp Ther (2001) 1.17
Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. Am J Respir Cell Mol Biol (2002) 1.13
Intratracheal double-stranded RNA plus interferon-gamma: a model for analysis of the acute phase response to respiratory viral infections. Life Sci (2004) 1.10
The role of viral infections in the natural history of asthma. J Allergy Clin Immunol (2000) 1.09
Elevated chemokine responses are maintained in lungs after clearance of viral infection. J Virol (2002) 1.07
Respiratory virus infections in cystic fibrosis. Paediatr Respir Rev (2003) 1.04
The murine homologue of the human interleukin-8 receptor type B maps near the Ity-Lsh-Bcg disease resistance locus. Genomics (1993) 1.01
Arthritogenic properties of double-stranded (viral) RNA. J Immunol (2004) 1.01
Cloning of a cDNA encoding a mouse homolog of the interleukin-8 receptor. Gene (1994) 1.00
CXC chemokine receptor 2 contributes to host defense in murine urinary tract infection. J Infect Dis (2001) 0.99
Acute inflammatory response and remodeling of airway epithelium after subspecies B1 human adenovirus infection of the mouse lower respiratory tract. J Med Virol (2003) 0.98
The spectrum of pathological changes in severe acute respiratory syndrome (SARS). Histopathology (2004) 0.96
Viruses and idiopathic pulmonary fibrosis. Monaldi Arch Chest Dis (2000) 0.94
Potential novel therapies for chronic obstructive pulmonary disease. Novartis Found Symp (2001) 0.93
Viral respiratory infection and the link to asthma. Pediatr Infect Dis J (2004) 0.87
Viral-induced inflammation in interstitial lung diseases. Semin Respir Infect (2003) 0.87
Early induction of proinflammatory cytokine and type I interferon mRNAs following Newcastle disease virus, poly [rI:rC], or low-dose LPS challenge of the mouse. J Interferon Cytokine Res (1997) 0.86
Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response. Eur Respir J (2003) 0.84
The adenovirus and bronchopulmonary dysplasia: an association that could be causal or coincidental. Pediatr Res (2000) 0.77
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest (2004) 7.91
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell (2008) 4.51
Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 4.41
IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest (2009) 3.30
Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest (2002) 3.08
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest (2009) 2.96
The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med (2003) 2.91
Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med (2015) 2.80
Elevated circulating fibrocyte levels in patients with hypertensive heart disease. J Hypertens (2012) 2.79
Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome. Am J Respir Crit Care Med (2014) 2.77
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun (2006) 2.52
Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer (2006) 2.50
The role of CXC chemokines in pulmonary fibrosis. J Clin Invest (2007) 2.41
Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol (2004) 2.34
Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest (2005) 2.20
Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol (2002) 2.05
An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat Immunol (2010) 2.03
CXC chemokines in angiogenesis. Cytokine Growth Factor Rev (2005) 2.00
Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol (2002) 1.95
High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest (2007) 1.92
Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem (2007) 1.91
Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. Int J Biochem Cell Biol (2009) 1.90
Fibrocytes in lung disease. J Leukoc Biol (2007) 1.89
High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res (2006) 1.84
The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol (2009) 1.76
Chemokines as mediators of neovascularization. Arterioscler Thromb Vasc Biol (2008) 1.71
NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. Blood (2009) 1.69
Characterization of human fibrocytes as circulating adipocyte progenitors and the formation of human adipose tissue in SCID mice. FASEB J (2005) 1.68
Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury. J Immunol (2006) 1.68
Cytokines in innate host defense in the lung. J Clin Invest (2002) 1.66
Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med (2012) 1.66
CXCR2 is critical to hyperoxia-induced lung injury. J Immunol (2004) 1.65
CXC chemokines in angiogenesis of cancer. Semin Cancer Biol (2004) 1.65
Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. J Clin Invest (2005) 1.61
BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res (2004) 1.58
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab (2009) 1.55
Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer (2006) 1.54
Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect Immun (2002) 1.54
Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. Cancer Res (2007) 1.53
Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol (2009) 1.44
The role of cytokines during the pathogenesis of ventilator-associated and ventilator-induced lung injury. Semin Respir Crit Care Med (2006) 1.44
The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol (2005) 1.44
CXC chemokines in cancer angiogenesis and metastases. Adv Cancer Res (2010) 1.44
Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma. Clin Cancer Res (2009) 1.43
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. Cancer Lett (2006) 1.41